UBE2T and cancer: Similar to this study, Cao et al. [7] conducted a pan-cancer analysis of UBE2T and found that its high expression is a prognostic risk factor in most cancers, possibly serving as a therapeutic target or a predictive factor for prognosis and immunotherapy sensitivity.